The diagnosis and management of occipital-atlantal and atlantoaxial instability in Down syndrome patients is a challenging problem in pediatric spine surgery. To date, no systematic review of this topic has been presented on this confusing and sometimes contentious issue. This topic review will focus on the biomechanical and radiographic foundations for which treatment recommendations in Down syndrome patients are made. In addition, otolaryngologic and anesthetic considerations in Down syndrome are also discussed, as well as advances in surgery that have made the operative fusion of these patients easier and safer.

Keywords:
Down syndrome, Craniovertebral instability, Pediatrics
1.
American Academy of Pediatrics CoSM: Atlantoaxial instability in Down syndrome. Pediatrics 1984;74:152–154.
2.
White AA, Panjabi MM: The clinical biomechanics of the occipitoatlantoaxial complex. Orthop Clin North Am 1978;9:867–878.
3.
American Academy of Pediatrics CoSMaF: Atlantoaxial instability in Down syndrome: Subject review. Pediatrics 1995;96:151–154.
4.
Msall M, Reese M, DiGaudio K, Griswold K, Granger C, Cook R: Symptomatic atlantoaxial instability associated with medical and rehabilitative procedures in children with Down syndrome. Pediatrics 1990;85:447–449.
5.
Moore R, McNicholas K, Warran S: Atlantoaxial subluxation with symptomatic spinal cord compression in a child with Down’s syndrome. Anesth Analg 1987;66:89–90.
6.
Williams J, Somerville G, Miner M, Reilly D: Atlanto-axial subluxation and Trisomy-21: Another perioperative complication. Anesthesiology 1987;67:253–254.
7.
Chaudry V, Sturgeon C, Gates A, Myers G: Symptomatic atlantoaxial dislocation in Down’s syndrome. Ann Neurol 1987;21:606–609.
8.
Nordt JC, Stauffer ES: Sequelae of atlantoaxial stabilization in two patients with Down’s syndrome. Spine 1981;6:437–440.
9.
Shikata J, Yamamuro T, Mikawa Y, Iida H, Kobori M: Surgical treatment of symptomatic atlantoaxial subluxation in Down’s syndrome. Clin Orthop 1987;220:111–118.
10.
Davidson RG: Atlantoaxial instability in individuals with Down syndrome: A fresh look at the evidence. Pediatrics 1988;81:857–865.
11.
Pueschel SM, Scola FH: Atlantoaxial instability in individuals with Down syndrome: Epidemiologic, radiographic, and clinical studies. Pediatrics 1987;80:555–560.
12.
Roy M, Baxter M, Roy A: Atlantoaxial instability in Down syndrome – Guidelines for screening and detection. J R Soc Med 1990;83:433–435.
13.
Pueschel SM, Scola FH, Tupper TB, Pezzullo JC: Skeletal anomalies of the upper cervical spine in children with Down syndrome. J Pediatr Orthop 1990;10:607–611.
14.
Selby KA, Newton RW, Gupta S, Hunt L: Clinical predictors and radiological reliability in atlantoaxial subluxation in Down’s syndrome. Arch Dis Child 1991;66:876–878.
15.
Pueschel SM, Moon AC, Scola FH: Computerized tomography in persons with Down syndrome and atlantoaxial instability. Spine 1992;17:735–737.
16.
White KS, Ball WS, Prenger EC, Patterson BJ, Kirks DR: Evaluation of the craniocervical junction in Down syndrome: Correlation of measurements obtained with radiography and MR imaging. Radiology 1993;186:377–382.
17.
Ferguson RL, Putney ME, Allen BL: Comparison of neurologic deficits with atlanto-dens intervals in patients with Down syndrome. J Spinal Disord 1997;10:246–252.
18.
Burke SW, French HG, Roberts JM, Johnston CE, Whitecloud TS, Edmunds JO: Chronic atlanto-axial instability in Down syndrome. J Bone Joint Surg 1985;67-A:1356–1360.
19.
Pueschel SM, Findley TW, Furia J, Gallagher PL, Scola FH, Pezzullo JC: Atlantoaxial instability in Down syndrome: Roentgenographic, neurologic, and somatosensory evoked potential studies. J Pediatr 1987;110:515–521.
20.
Ohsawa T, Izawa T, Kuroki Y, Ohnari K: Follow-up study of atlanto-axial instability in Down’s syndrome without separate odontoid process. Spine 1989;13:1149–1153.
21.
Pueschel SM, Scola FH, Pezzullo JC: A longitudinal study of atlanto-dens relationships in asymptomatic individuals with Down syndrome. Pediatrics 1992;89:1194–1198.
22.
Morton RE, Khan MA, Murray-Leslie C, Elliott S: Atlantoaxial instability in Down’s syndrome: A five year follow up study. Arch Dis Child 1995;72:115–119.
23.
Tredwell SJ, Newman DE, Lockitch G: Instability of the upper cervical spine in Down syndrome. J Pediatr Orthop 1990;10:602–606.
24.
Menezes AH, Ryken TC: Carniovertebral abnormalities in Down’s syndrome. Pediatr Neurosurg 1992;18:24–33.
25.
Harley EH, Collins MD: Neurologic sequelae secondary to atlantoaxial instability in Down syndrome. Arch Otolaryngol Head Neck Surg 1994;120:159–165.
26.
Mitchell V, Howard R, Facer E: Down’s syndrome and anaesthesia. Paediatr Anaesth 1995;5:379–384.
27.
Segal LS, Drummond DS, Zanotti RM, Ecker ML, Mubarak SJ: Complications of posterior arthrodesis of the cervical spine in patients who have Down syndrome. J Bone Joint Surg 1991;73-A:1547–1554.
28.
Doyle JS, Lauerman WC, Wood KB, Krause DR: Complications and long-term outcome of upper cervical spine arthrodesis in patients with Down syndrome. Spine 1996;21:1223–1231.
29.
Brockmeyer D, Apfelbaum R: A new occipitocervical fusion construct in pediatric patients with occipitocervical instability. J Neurosurg (Spine 2) 1999;90:271–275.
© 1999 S. Karger AG, Basel
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.